3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pain
1
Breast Diseases
1
Agnosia
1
Interventions
ribociclib
2
palbociclib
2
Gonadotropin-Releasing Hormone
2
Doxorubicin
2
Docetaxel
2
Anastrozole
2
AZD9833
2
trastuzumab deruxtecan
1
taxane
1
pertuzumab
1
pegfilgrastim
1
ipatasertib
1
atezolizumab
1
abemaciclib
1
Trastuzumab
1
Sodium Chloride
1
Paclitaxel
1
Letrozole
1
Ibuprofen
1
Fulvestrant
1
Drug Therapy
1
Denosumab
1
Cyclophosphamide
1
Codeine
1
Capecitabine
1
Botulinum Toxins, Type A
1
Bevacizumab
1
Acetaminophen
1
2,2'-dithiodiethanesulfonic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Breast Diseases
×
Codeine
×
Clear all
NCT00299039
2009-02-02
T3AI
Nova Scotia Health Authority
Phase 3
Completed
150 enrolled